Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
(FMCLRHTZMTUYMI-JFQFMQNHSA-N)
Structure
- SMILES
- Nc1nc(=O)n(cc1F)[C@@H]1CS[C@@H](O1)CO.C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.O=C(N[C@@H](Cc1ccccc1)CC[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1.OC(=O)/C=C/C(=O)O.OC[C@@H](n1cc(C(=O)O)c(=O)c2c1cc(OC)c(c2)Cc1cccc(c1F)Cl)C(C)C
- Molecular Formula:
- C94H120ClF2N16O27PS3
- Molecular Weight:
- 2106.670
- Log P:
- 14.8471
- Hydrogen Bond Acceptor:
- 46
- Hydrogen Bond Donor:
- 10
- TPSA:
- 668.78
- CAS Number(s):
- 1430117-57-9
Synonym(s)
1.
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2.
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate
3.
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination
4.
Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination
5.
Quad
6.
Quad Pill
7.
Stribild
8.
Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination
9.
Pill, Quad
External Link(s)
| MeSH | D000069545 |
| PubChem Compound | 44232548 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Anxiety | FAERS: 75 | US FAERS | |
| 2 | Pain | FAERS: 73 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 3 | Economic problem | FAERS: 65 | US FAERS | |
| 4 | Anhedonia | FAERS: 64 | US FAERS | |
| 5 | Emotional distress | FAERS: 64 | US FAERS | |
| 6 | Nausea | FAERS: 39 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Bone density decreased | FAERS: 38 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Osteoporosis | FAERS: 36 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Fatigue | FAERS: 31 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 10 | Myalgia | FAERS: 30 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 11 | Drug ineffective | FAERS: 24 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 12 | Drug dose omission | FAERS: 20 | US FAERS | |
| 13 | Arthralgia | FAERS: 18 | US FAERS | |
| 14 | Viral load increased | FAERS: 18 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 15 | Vomiting | FAERS: 18 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | Alopecia | FAERS: 17 | US FAERS | |
| 17 | Headache | FAERS: 15 | US FAERS | |
| 18 | Asthenia | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 19 | Back Pain | FAERS: 14 | US FAERS | |
| 20 | Blood creatinine increased | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 21 | Malaise | FAERS: 13 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 22 | Dizziness | FAERS: 11 | US FAERS | |
| 23 | Drug resistance | FAERS: 10 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 24 | Pruritus | FAERS: 10 | US FAERS | |
| 25 | Urticaria | FAERS: 10 | US FAERS | |
| 26 | Weight decreased | FAERS: 10 | US FAERS | |
| 27 | CD4 Lymphocytes Decreased | FAERS: 9 | US FAERS | |
| 28 | Abdominal Pain | FAERS: 8 | US FAERS | |
| 29 | Feeling abnormal | FAERS: 8 | US FAERS | |
| 30 | Myocardial Infarction | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 31 | Unevaluable event | FAERS: 8 | US FAERS | |
| 32 | Wrong technique in product usage process | FAERS: 8 | US FAERS | |
| 33 | Bone pain | FAERS: 7 | US FAERS | |
| 34 | Intentional dose omission | FAERS: 7 | US FAERS | |
| 35 | Therapy cessation | FAERS: 7 | US FAERS | |
| 36 | Chills | FAERS: 6 | US FAERS | |
| 37 | Immune Reconstitution Inflammatory Syndrome | FAERS: 6 | US FAERS | |
| 38 | Osteopenia | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 39 | Syncope | FAERS: 6 | US FAERS | |
| 40 | Tooth Loss | FAERS: 6 | US FAERS | |
| 41 | Blood HIV RNA increased | FAERS: 5 | US FAERS | |
| 42 | Blood creatine increased | FAERS: 5 | US FAERS | |
| 43 | Blood creatine phosphokinase increased | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 44 | Bone density abnormal | FAERS: 5 | US FAERS | |
| 45 | Chest Pain | FAERS: 5 | US FAERS | |
| 46 | Constipation | FAERS: 5 | US FAERS | |
| 47 | Drug screen false positive | FAERS: 5 | US FAERS | |
| 48 | Genotype drug resistance test positive | FAERS: 5 | US FAERS | |
| 49 | Nasopharyngitis | FAERS: 5 | US FAERS | |
| 50 | Nephrolithiasis | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 51 | Pancreatitis | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 52 | Pregnancy | FAERS: 5 | US FAERS | |
| 53 | Somnolence | FAERS: 5 | US FAERS | |
| 54 | Abdominal discomfort | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 55 | Alanine Aminotransferase Increased | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 56 | Amnesia | FAERS: 4 | US FAERS | |
| 57 | Aspartate Aminotransferase Increased | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 58 | Breast tenderness | FAERS: 4 | US FAERS | |
| 59 | Drug screen positive | FAERS: 4 | US FAERS | |
| 60 | Dyspepsia | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 61 | Gout | FAERS: 4 | US FAERS | |
| 62 | Hypersensitivity | FAERS: 4 | US FAERS | |
| 63 | Lip swelling | FAERS: 4 | US FAERS | |
| 64 | Loss of personal independence in daily activities | FAERS: 4 | US FAERS | |
| 65 | Neutropenia | FAERS: 4 | US FAERS | |
| 66 | Pathogen resistance | FAERS: 4 | US FAERS | |
| 67 | Proteinuria | FAERS: 4 | US FAERS | |
| 68 | Rhabdomyolysis | FAERS: 4 | US FAERS | |
| 69 | Vertigo | FAERS: 4 | US FAERS | |
| 70 | Accidental overdose | FAERS: 3 | US FAERS | |
| 71 | Acute kidney injury | FAERS: 3 | US FAERS | |
| 72 | Atrial Fibrillation | FAERS: 3 | US FAERS | |
| 73 | Blood creatinine abnormal | FAERS: 3 | US FAERS | |
| 74 | Blood phosphorus decreased | FAERS: 3 | US FAERS | |
| 75 | Blood triglycerides increased | FAERS: 3 | US FAERS | |
| 76 | Bronchitis | FAERS: 3 | US FAERS | |
| 77 | Chromaturia | FAERS: 3 | US FAERS | |
| 78 | Diabetes Mellitus | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 79 | Eczema | FAERS: 3 | US FAERS | |
| 80 | Flatulence | FAERS: 3 | US FAERS | |
| 81 | Fracture | FAERS: 3 | US FAERS | |
| 82 | Glycosuria | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 83 | Hepatitis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 84 | Intentional product misuse | FAERS: 3 | US FAERS | |
| 85 | Lipodystrophy acquired | FAERS: 3 | US FAERS | |
| 86 | Lymphoma | FAERS: 3 | US FAERS | |
| 87 | Menorrhagia | FAERS: 3 | US FAERS | |
| 88 | Muscle strain | FAERS: 3 | US FAERS | |
| 89 | Musculoskeletal Pain | FAERS: 3 | US FAERS | |
| 90 | Overdose | FAERS: 3 | US FAERS | |
| 91 | Product difficult to swallow | FAERS: 3 | US FAERS | |
| 92 | Product dose omission | FAERS: 3 | US FAERS | |
| 93 | Product physical issue | FAERS: 3 | US FAERS | |
| 94 | Product quality issue | FAERS: 3 | US FAERS | |
| 95 | Pulmonary Embolism | FAERS: 3 | US FAERS | |
| 96 | Visual Impairment | FAERS: 3 | US FAERS | |
| 97 | treatment failure | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 98 | Anger | FAERS: 2 | US FAERS | |
| 99 | Blood potassium decreased | FAERS: 2 | US FAERS | |
| 100 | Burning sensation | FAERS: 2 | US FAERS | |
| 101 | Cardiac Arrest | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 102 | Completed Suicide | FAERS: 2 | US FAERS | |
| 103 | Crying | FAERS: 2 | US FAERS | |
| 104 | Dental caries | FAERS: 2 | US FAERS | |
| 105 | Dry skin | FAERS: 2 | US FAERS | |
| 106 | Erectile dysfunction | FAERS: 2 | US FAERS | |
| 107 | Gene mutation identification test positive | FAERS: 2 | US FAERS | |
| 108 | General physical health deterioration | FAERS: 2 | US FAERS | |
| 109 | Genital Herpes | FAERS: 2 | US FAERS | |
| 110 | Hidradenitis | FAERS: 2 | US FAERS | |
| 111 | Hypersomnia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 112 | Impaired work ability | FAERS: 2 | US FAERS | |
| 113 | Inability to afford medication | FAERS: 2 | US FAERS | |
| 114 | Inflammation | FAERS: 2 | US FAERS | |
| 115 | Insurance issue | FAERS: 2 | US FAERS | |
| 116 | Intentional drug misuse | FAERS: 2 | US FAERS | |
| 117 | Intentional product use issue | FAERS: 2 | US FAERS | |
| 118 | Joint injury | FAERS: 2 | US FAERS | |
| 119 | Malabsorption | FAERS: 2 | US FAERS | |
| 120 | Maternal exposure during pregnancy | FAERS: 2 | US FAERS | |
| 121 | Memory impairment | FAERS: 2 | US FAERS | |
| 122 | Mental status changes | FAERS: 2 | US FAERS | |
| 123 | Multiple allergies | FAERS: 2 | US FAERS | |
| 124 | Muscle tightness | FAERS: 2 | US FAERS | |
| 125 | Night sweats | FAERS: 2 | US FAERS | |
| 126 | Phlebitis | FAERS: 2 | US FAERS | |
| 127 | Pneumonia | FAERS: 2 | US FAERS | |
| 128 | Premature Ejaculation | FAERS: 2 | US FAERS | |
| 129 | Product storage error | FAERS: 2 | US FAERS | |
| 130 | Product use complaint | FAERS: 2 | US FAERS | |
| 131 | Product use issue | FAERS: 2 | US FAERS | |
| 132 | Quality of life decreased | FAERS: 2 | US FAERS | |
| 133 | Renal pain | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 134 | Restlessness | FAERS: 2 | US FAERS | |
| 135 | Sinusitis | FAERS: 2 | US FAERS | |
| 136 | Stomatitis | FAERS: 2 | US FAERS | |
| 137 | Thrombocytopenia | FAERS: 2 | US FAERS | |
| 138 | Thyroiditis | FAERS: 2 | US FAERS | |
| 139 | Tinnitus | FAERS: 2 | US FAERS | |
| 140 | Tremor | FAERS: 2 | US FAERS | |
| 141 | Tuberculosis | FAERS: 2 | US FAERS | |
| 142 | Urine phosphorus abnormal | FAERS: 2 | US FAERS | |
| 143 | Vasculitis | FAERS: 2 | US FAERS | |
| 144 | Viral mutation identified | FAERS: 2 | US FAERS | |
| 145 | Wrong technique in drug usage process | FAERS: 2 | US FAERS | |
| 146 | nervous system disorder | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 147 | Abnormal sleep-related event | FAERS: 1 | US FAERS | |
| 148 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 149 | Acne | FAERS: 1 | US FAERS | |
| 150 | Activities of daily living impaired | FAERS: 1 | US FAERS | |
| 151 | Acute HIV infection | FAERS: 1 | US FAERS | |
| 152 | Acute hepatitis C | FAERS: 1 | US FAERS | |
| 153 | Ageusia | FAERS: 1 | US FAERS | |
| 154 | Agitation | FAERS: 1 | US FAERS | |
| 155 | Alanine aminotransferase abnormal | FAERS: 1 | US FAERS | |
| 156 | Alcohol abuse | FAERS: 1 | US FAERS | |
| 157 | Alcohol interaction | FAERS: 1 | US FAERS | |
| 158 | Allodynia | FAERS: 1 | US FAERS | |
| 159 | Amphetamines positive | FAERS: 1 | US FAERS | |
| 160 | Amylase increased | FAERS: 1 | US FAERS | |
| 161 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 162 | Angioedema | FAERS: 1 | US FAERS | |
| 163 | Ankle Fracture | FAERS: 1 | US FAERS | |
| 164 | Anorgasmia | FAERS: 1 | US FAERS | |
| 165 | Arthritis | FAERS: 1 | US FAERS | |
| 166 | Arthrodesis | FAERS: 1 | US FAERS | |
| 167 | Arthropod bite | FAERS: 1 | US FAERS | |
| 168 | Aspartate aminotransferase abnormal | FAERS: 1 | US FAERS | |
| 169 | Asthma | FAERS: 1 | US FAERS | |
| 170 | Autoimmune thyroid disorder | FAERS: 1 | US FAERS | |
| 171 | Axonal neuropathy | FAERS: 1 | US FAERS | |
| 172 | Basal cell carcinoma | FAERS: 1 | US FAERS | |
| 173 | Bipolar I disorder | FAERS: 1 | US FAERS | |
| 174 | Bladder pain | FAERS: 1 | US FAERS | |
| 175 | Blood cholesterol increased | FAERS: 1 | US FAERS | |
| 176 | Blood creatine phosphokinase abnormal | FAERS: 1 | US FAERS | |
| 177 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 178 | Blood magnesium decreased | FAERS: 1 | US FAERS | |
| 179 | Blood phosphorus increased | FAERS: 1 | US FAERS | |
| 180 | CD4 lymphocytes increased | FAERS: 1 | US FAERS | |
| 181 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 182 | Cataplexy | FAERS: 1 | US FAERS | |
| 183 | Cataract | FAERS: 1 | US FAERS | |
| 184 | Cerebrovascular accident | FAERS: 1 | US FAERS | |
| 185 | Chemotherapy | FAERS: 1 | US FAERS | |
| 186 | Chest discomfort | FAERS: 1 | US FAERS | |
| 187 | Choking | FAERS: 1 | US FAERS | |
| 188 | Cholangiocarcinoma | FAERS: 1 | US FAERS | |
| 189 | Cluster Headache | FAERS: 1 | US FAERS | |
| 190 | Colitis | FAERS: 1 | US FAERS | |
| 191 | Conjunctivitis | FAERS: 1 | US FAERS | |
| 192 | Cyanosis | FAERS: 1 | US FAERS | |
| 193 | Deep Vein Thrombosis | FAERS: 1 | US FAERS | |
| 194 | Dehydration | FAERS: 1 | US FAERS | |
| 195 | Dementia | FAERS: 1 | US FAERS | |
| 196 | Dental cosmetic procedure | FAERS: 1 | US FAERS | |
| 197 | Depressed mood | FAERS: 1 | US FAERS | |
| 198 | Depression suicidal | FAERS: 1 | US FAERS | |
| 199 | Diabetic Ketoacidosis | FAERS: 1 | US FAERS | |
| 200 | Disease complication | FAERS: 1 | US FAERS | |
| 201 | Diverticular perforation | FAERS: 1 | US FAERS | |
| 202 | Diverticulitis | FAERS: 1 | US FAERS | |
| 203 | Drug administration error | FAERS: 1 | US FAERS | |
| 204 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 205 | Drug level above therapeutic | FAERS: 1 | US FAERS | |
| 206 | Drug screen negative | FAERS: 1 | US FAERS | |
| 207 | Duodenal Ulcer | FAERS: 1 | US FAERS | |
| 208 | Dysarthria | FAERS: 1 | US FAERS | |
| 209 | Dysgeusia | FAERS: 1 | US FAERS | |
| 210 | Dysuria | FAERS: 1 | US FAERS | |
| 211 | Ejection Fraction Decreased | FAERS: 1 | US FAERS | |
| 212 | Emergency care examination | FAERS: 1 | US FAERS | |
| 213 | Emotional disorder | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 214 | Endocarditis | FAERS: 1 | US FAERS | |
| 215 | Eosinophilic pustular folliculitis | FAERS: 1 | US FAERS | |
| 216 | Eructation | FAERS: 1 | US FAERS | |
| 217 | Erythema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 218 | Extra dose administered | FAERS: 1 | US FAERS | |
| 219 | Extraocular Muscle Paresis | FAERS: 1 | US FAERS | |
| 220 | False positive investigation result | FAERS: 1 | US FAERS | |
| 221 | Fanconi Syndrome | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 222 | Fat redistribution | FAERS: 1 | US FAERS | |
| 223 | Feeding tube complication | FAERS: 1 | US FAERS | |
| 224 | Feeling Cold | FAERS: 1 | US FAERS | |
| 225 | Flushing | FAERS: 1 | US FAERS | |
| 226 | Foreign body aspiration | FAERS: 1 | US FAERS | |
| 227 | Gastric Bypass | FAERS: 1 | US FAERS | |
| 228 | Gastric Dilatation | FAERS: 1 | US FAERS | |
| 229 | Gastric pH decreased | FAERS: 1 | US FAERS | |
| 230 | Gastritis | FAERS: 1 | US FAERS | |
| 231 | Gingival Recession | FAERS: 1 | US FAERS | |
| 232 | Glaucoma | FAERS: 1 | US FAERS | |
| 233 | Hepatitis B | FAERS: 1 | US FAERS | |
| 234 | Hepatomegaly | FAERS: 1 | US FAERS | |
| 235 | Hyperlipasaemia | FAERS: 1 | US FAERS | |
| 236 | Hypotension | FAERS: 1 | US FAERS | |
| 237 | Immune thrombocytopenic purpura | FAERS: 1 | US FAERS | |
| 238 | Inappropriate schedule of drug administration | FAERS: 1 | US FAERS | |
| 239 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 240 | Incorrect product storage | FAERS: 1 | US FAERS | |
| 241 | Infarction | FAERS: 1 | US FAERS | |
| 242 | Infection | FAERS: 1 | US FAERS | |
| 243 | Joint Range of Motion Decreased | FAERS: 1 | US FAERS | |
| 244 | Laceration | FAERS: 1 | US FAERS | |
| 245 | Limb discomfort | FAERS: 1 | US FAERS | |
| 246 | Lipoatrophy | FAERS: 1 | US FAERS | |
| 247 | Lipoma | FAERS: 1 | US FAERS | |
| 248 | Lower respiratory tract infection | FAERS: 1 | US FAERS | |
| 249 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 250 | Medication Error | FAERS: 1 | US FAERS | |
| 251 | Meningomyelocele | FAERS: 1 | US FAERS | |
| 252 | Myopathy | FAERS: 1 | US FAERS | |
| 253 | Myosclerosis | FAERS: 1 | US FAERS | |
| 254 | Myositis | FAERS: 1 | US FAERS | |
| 255 | Nephrotic Syndrome | FAERS: 1 | US FAERS | |
| 256 | Neuralgia | FAERS: 1 | US FAERS | |
| 257 | Neutrophil count decreased | FAERS: 1 | US FAERS | |
| 258 | Neutrophilic dermatosis | FAERS: 1 | US FAERS | |
| 259 | Nonspecific reaction | FAERS: 1 | US FAERS | |
| 260 | Optic Neuritis | FAERS: 1 | US FAERS | |
| 261 | Oral infection | FAERS: 1 | US FAERS | |
| 262 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 263 | Palpitations | FAERS: 1 | US FAERS | |
| 264 | Pancytopenia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 265 | Pathological fracture | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 266 | Periarthritis | FAERS: 1 | US FAERS | |
| 267 | Peripheral artery thrombosis | FAERS: 1 | US FAERS | |
| 268 | Peripheral swelling | FAERS: 1 | US FAERS | |
| 269 | Platelet dysfunction | FAERS: 1 | US FAERS | |
| 270 | Portal Vein Thrombosis | FAERS: 1 | US FAERS | |
| 271 | Product availability issue | FAERS: 1 | US FAERS | |
| 272 | Product closure issue | FAERS: 1 | US FAERS | |
| 273 | Product dispensing error | FAERS: 1 | US FAERS | |
| 274 | Product packaging confusion | FAERS: 1 | US FAERS | |
| 275 | Product prescribing error | FAERS: 1 | US FAERS | |
| 276 | Product prescribing issue | FAERS: 1 | US FAERS | |
| 277 | Product substitution issue | FAERS: 1 | US FAERS | |
| 278 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 279 | Pseudarthrosis | FAERS: 1 | US FAERS | |
| 280 | Pubic pain | FAERS: 1 | US FAERS | |
| 281 | Renal cyst | FAERS: 1 | US FAERS | |
| 282 | Renal tubular disorder | FAERS: 1 | US FAERS | |
| 283 | Respiratory tract congestion | FAERS: 1 | US FAERS | |
| 284 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 285 | Retching | FAERS: 1 | US FAERS | |
| 286 | Rheumatoid Arthritis | FAERS: 1 | US FAERS | |
| 287 | Sciatica | FAERS: 1 | US FAERS | |
| 288 | Skin irritation | FAERS: 1 | US FAERS | |
| 289 | Sleep disorder due to general medical condition, insomnia type | FAERS: 1 | US FAERS | |
| 290 | Somnambulism | FAERS: 1 | US FAERS | |
| 291 | Splenomegaly | FAERS: 1 | US FAERS | |
| 292 | Staphylococcus test positive | FAERS: 1 | US FAERS | |
| 293 | Suicide attempt | FAERS: 1 | US FAERS | |
| 294 | Suspected counterfeit product | FAERS: 1 | US FAERS | |
| 295 | Tachycardia | FAERS: 1 | US FAERS | |
| 296 | Therapy change | FAERS: 1 | US FAERS | |
| 297 | Thirst | FAERS: 1 | US FAERS | |
| 298 | Thyroid hormones decreased | FAERS: 1 | US FAERS | |
| 299 | Toothache | FAERS: 1 | US FAERS | |
| 300 | Toxic Epidermal Necrolysis | FAERS: 1 | US FAERS | |
| 301 | Toxic Optic Neuropathy | FAERS: 1 | US FAERS | |
| 302 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 303 | Transaminases increased | FAERS: 1 | US FAERS | |
| 304 | Trichorrhexis | FAERS: 1 | US FAERS | |
| 305 | Ulcer | FAERS: 1 | US FAERS | |
| 306 | VIIth nerve paralysis | FAERS: 1 | US FAERS | |
| 307 | Varicella virus test positive | FAERS: 1 | US FAERS | |
| 308 | Viral load undetectable | FAERS: 1 | US FAERS | |
| 309 | Viral myositis | FAERS: 1 | US FAERS | |
| 310 | Virologic failure | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 311 | Waist circumference increased | FAERS: 1 | US FAERS | |
| 312 | Walking aid user | FAERS: 1 | US FAERS | |
| 313 | White blood cell count decreased | FAERS: 1 | US FAERS | |
| 314 | Flank Pain | Canada Vigilance: 2 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.